Prof. Ademola Alabi of the Department of Surgery, University of Ilorin (UNILORIN) says
arrangements have been concluded for a multi-centre study in the country towards improving the outcome of prostate cancer cases, using Vitamin D supplements.
Alabi made this known in Ilorin while delivering the 250th Inaugural Lecture of the university entitled “That All May Pee in Peace.”
He explained that the study commenced in Mayo Clinic, Florida and six other sites, and will include Ilorin, in Nigeria.
The don, who said that he is designated as the National Principal Investigator in Nigeria, added that “insurance for participants and
ethics approval have been obtained for the Ilorin study to commence.”
The expert who teaches in the Faculty of Clinical Sciences, College of Health Sciences of the university, pointed out that
“the study intends to look at the role of Vitamin D in prostate cancer patients’ immunity.
“We will investigate and see if Vitamin D supplements can help to improve immunity and outcomes in patients with prostate cancer.”
He said that the research is under the Transatlantic Prostate Cancer Consortium (CaPTC), which has conducted landmark research on the disease.
“We guided Nigerian pathologists in the preparation of Formalin Fixed Paraffin Embedded (FFPE) prostate specimens.
“This is with the outcome being that a good number of FFPE specimens from six Nigerian institutions will comply with international standards and useable as biospecimens for various genetic studies,” he said. READ ALSO:
- Kemi Badenoch’s Yoruba identity meets inconvenient truths
- Lone accident kills 3 varsity students in Ogun
- Premier League: Arsenal Thrash Crystal Palace In London Derby
- Stampede: Police warn against unorganised palliatives distribution
- Dangote, MRS partner to sell petrol at ₦935 nationwide
He, therefore, suggested that the National Health Insurance policy should cover screening, evaluation and treatment of
prostate cancer and related ailments affecting all ages and gender. (NAN)
